Effect of age and BW on the percentage of different blood mononuclear immune cell subsets and on the plasma concentrations of IGF-1 in HBW and LBW piglets
Variable . | Day . | BW . | . | SEM . | P-value . | . | . |
---|---|---|---|---|---|---|---|
. | . | HBW . | LBW . | . | AGE . | BW . | AGE × BW . |
T lymphocytes (CD3+) | |||||||
Helper (CD4+CD8α −) | 20 | 20.5b | 24.2a | 1.1 | 0.09 | 0.05 | 0.03 |
42 | 20.6 | 21.1 | 1.0 | ||||
Cytotoxic (CD4−CD8α high) | 20 | 6.1 | 6.0 | 0.4 | 0.80 | 0.89 | 0.44 |
42 | 6.0 | 5.9 | 0.4 | ||||
γδ (γδ +) | 20 | 19.7 | 16.7 | 0.9 | 0.59 | 0.006 | 0.57 |
42 | 19.0 | 16.6 | 0.9 | ||||
B lymphocytes (CD3–CD21+) | 20 | 19.8a | 18.2b | 1.2 | 0.003 | 0.73 | ˂0.001 |
42 | 20.6b | 22.7a | 0.7 | ||||
NK cells (CD3−CD8α lowCD16+) | 20 | 15.7 | 16.6 | 1.4 | 0.65 | 0.95 | 0.39 |
42 | 16.1 | 15.3 | 1.6 | ||||
IGF-1, ng/mL | 20 | 77.4 | 61.3 | 2.8 | ˂0.001 | ˂0.001 | 0.99 |
42 | 102.5 | 86.3 | 4.8 |
Variable . | Day . | BW . | . | SEM . | P-value . | . | . |
---|---|---|---|---|---|---|---|
. | . | HBW . | LBW . | . | AGE . | BW . | AGE × BW . |
T lymphocytes (CD3+) | |||||||
Helper (CD4+CD8α −) | 20 | 20.5b | 24.2a | 1.1 | 0.09 | 0.05 | 0.03 |
42 | 20.6 | 21.1 | 1.0 | ||||
Cytotoxic (CD4−CD8α high) | 20 | 6.1 | 6.0 | 0.4 | 0.80 | 0.89 | 0.44 |
42 | 6.0 | 5.9 | 0.4 | ||||
γδ (γδ +) | 20 | 19.7 | 16.7 | 0.9 | 0.59 | 0.006 | 0.57 |
42 | 19.0 | 16.6 | 0.9 | ||||
B lymphocytes (CD3–CD21+) | 20 | 19.8a | 18.2b | 1.2 | 0.003 | 0.73 | ˂0.001 |
42 | 20.6b | 22.7a | 0.7 | ||||
NK cells (CD3−CD8α lowCD16+) | 20 | 15.7 | 16.6 | 1.4 | 0.65 | 0.95 | 0.39 |
42 | 16.1 | 15.3 | 1.6 | ||||
IGF-1, ng/mL | 20 | 77.4 | 61.3 | 2.8 | ˂0.001 | ˂0.001 | 0.99 |
42 | 102.5 | 86.3 | 4.8 |
a,bAnalysis by day: within a row, means without a common superscript differ.
Effect of age and BW on the percentage of different blood mononuclear immune cell subsets and on the plasma concentrations of IGF-1 in HBW and LBW piglets
Variable . | Day . | BW . | . | SEM . | P-value . | . | . |
---|---|---|---|---|---|---|---|
. | . | HBW . | LBW . | . | AGE . | BW . | AGE × BW . |
T lymphocytes (CD3+) | |||||||
Helper (CD4+CD8α −) | 20 | 20.5b | 24.2a | 1.1 | 0.09 | 0.05 | 0.03 |
42 | 20.6 | 21.1 | 1.0 | ||||
Cytotoxic (CD4−CD8α high) | 20 | 6.1 | 6.0 | 0.4 | 0.80 | 0.89 | 0.44 |
42 | 6.0 | 5.9 | 0.4 | ||||
γδ (γδ +) | 20 | 19.7 | 16.7 | 0.9 | 0.59 | 0.006 | 0.57 |
42 | 19.0 | 16.6 | 0.9 | ||||
B lymphocytes (CD3–CD21+) | 20 | 19.8a | 18.2b | 1.2 | 0.003 | 0.73 | ˂0.001 |
42 | 20.6b | 22.7a | 0.7 | ||||
NK cells (CD3−CD8α lowCD16+) | 20 | 15.7 | 16.6 | 1.4 | 0.65 | 0.95 | 0.39 |
42 | 16.1 | 15.3 | 1.6 | ||||
IGF-1, ng/mL | 20 | 77.4 | 61.3 | 2.8 | ˂0.001 | ˂0.001 | 0.99 |
42 | 102.5 | 86.3 | 4.8 |
Variable . | Day . | BW . | . | SEM . | P-value . | . | . |
---|---|---|---|---|---|---|---|
. | . | HBW . | LBW . | . | AGE . | BW . | AGE × BW . |
T lymphocytes (CD3+) | |||||||
Helper (CD4+CD8α −) | 20 | 20.5b | 24.2a | 1.1 | 0.09 | 0.05 | 0.03 |
42 | 20.6 | 21.1 | 1.0 | ||||
Cytotoxic (CD4−CD8α high) | 20 | 6.1 | 6.0 | 0.4 | 0.80 | 0.89 | 0.44 |
42 | 6.0 | 5.9 | 0.4 | ||||
γδ (γδ +) | 20 | 19.7 | 16.7 | 0.9 | 0.59 | 0.006 | 0.57 |
42 | 19.0 | 16.6 | 0.9 | ||||
B lymphocytes (CD3–CD21+) | 20 | 19.8a | 18.2b | 1.2 | 0.003 | 0.73 | ˂0.001 |
42 | 20.6b | 22.7a | 0.7 | ||||
NK cells (CD3−CD8α lowCD16+) | 20 | 15.7 | 16.6 | 1.4 | 0.65 | 0.95 | 0.39 |
42 | 16.1 | 15.3 | 1.6 | ||||
IGF-1, ng/mL | 20 | 77.4 | 61.3 | 2.8 | ˂0.001 | ˂0.001 | 0.99 |
42 | 102.5 | 86.3 | 4.8 |
a,bAnalysis by day: within a row, means without a common superscript differ.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.